Parcion Private Wealth LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1801263
BELLEVUE, WA
Position in REGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$637,257
-$285,275 QoQ
Shares Held
1,022
-14.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#748
of 1,329 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parcion Private Wealth LLC holds $2,809,080 across 8 Biotechnology names. REGN ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,633 | $638,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,022 | $637,257 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,443 | $622,613 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
596 | $296,051 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
4,579 | $262,010 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
944 | $227,475 | |
| 7 | MNKD |
Mannkind Corp
|
15,709 | $66,920 | |
| 8 | FATE |
Fate Therapeutics Inc
|
21,555 | $58,198 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $637,257 | 1,022 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $922,532 | 1,194 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $913,122 | 1,183 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $277,760 | 494 | Shares | Other | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||